PMC3103261_01
Biochemical and viral parameters at admission and subsequent controls. Alanine aminotransferase (ALT) UI/mL, prothrombin time activity percentage (PT), hepatitis B antigen (HBsAg) UI/mL, antibody antiHBs (anti HBs), Hepatitis B DNA (HBV-DNA) UI/mL.
mjhid-3-1-e2011010f1.jpg
PMC3103261_01_mjhid-3-1-e2011010f1.jpg
f1-mjhid-3-1-e2011010
Ten days after the start of entecavir treatment, the laboratory exams confirmed the improvement of hepatic function: INR 1.21, ammonia 79 mg/dL, total cholesterol level 159 mg/dL, AST 72 mU/mL, ALT 261 mU/mL, total bilirubin level 13.29 mg/dL (Figure 1). Hepatitis markers revealed: HBsAg and quantitative HBsAg both negative and HBV DNA 65 UI/mL (Figure 1). HBV DNA wasn't detected after six weeks (figure 1).